Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yi Ji, Jialin Gu, Hongqun Zhang & Houxi Xu. (2023) Identification and Validation of Key miRNAs for Colon Cancer Based on miRNA-Gene Integration Analysis. International Journal of General Medicine 16, pages 5703-5718.
Read now
Read now
Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian-Robati, Hossein Ebrahimi, Faezeh Hosseini Pirhayati, Waleed H. Almalki, Pedram Ebrahimnejad & Prashant Kesharwani. (2023) Recent advances in novel miRNA mediated approaches for targeting breast cancer. Journal of Drug Targeting 31:8, pages 777-793.
Read now
Read now
Amir Yarahmadi, Romoye Sohan, Brenna McAllister & Leslie A. Caromile. (2022) Therapeutic potential of targeting mirnas to prostate cancer tumors: using psma as an active target. Molecular & Cellular Oncology 9:1.
Read now
Read now
Charles Asakiya, Liye Zhu, Jieyu Yuhan, Longjiao Zhu, Kunlun Huang & Wentao Xu. (2022) Current progress of miRNA-derivative nucleotide drugs: modifications, delivery systems, applications. Expert Opinion on Drug Delivery 19:4, pages 435-450.
Read now
Read now
Articles from other publishers (80)
Abdullah Al Shamsh Prottay, Mehedi Hasan Bappi, Md Showkoth Akbor, Afia Ibnath Asha, Md Shimul Bhuia, Aqib Adnan Shafin, Md Nayem Mia, Mohammad S. Mubarak, Micheline de Azevedo Lima, Henrique Douglas Melo Coutinho & Muhammad Torequl Islam. (2024) Sclareol exerts an anti-inflammatory effect, possibly through COXs inhibition pathway: In vivo and in silico studies. Pharmaceutical Science Advances 2, pages 100029.
Crossref
Crossref
Mounisha Bandakinda & Awanish Mishra. (2023) Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective. International Journal of Biological Macromolecules 253, pages 126561.
Crossref
Crossref
Samuel L. Neff, Thomas H. Hampton, Katja Koeppen, Sharanya Sarkar, Casey J. Latario, Benjamin D. Ross & Bruce A. Stanton. (2023) Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development. mSystems.
Crossref
Crossref
Emman Asjad & Halina Dobrzynski. (2023) MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment. International Journal of Molecular Sciences 24:22, pages 16207.
Crossref
Crossref
Maria Pagoni, Claudia Cava, Diamantis C. Sideris, Margaritis Avgeris, Vassilios Zoumpourlis, Ioannis Michalopoulos & Nikolaos Drakoulis. (2023) miRNA-Based Technologies in Cancer Therapy. Journal of Personalized Medicine 13:11, pages 1586.
Crossref
Crossref
Ana F. Almeida, Margarida S. Miranda, Adriana Vinhas, Márcia T. Rodrigues & Manuela E. Gomes. (2023) Contactless Resolution of Inflammatory Signals in Tailored Macrophage-Based Cell Therapeutics. ACS Applied Materials & Interfaces 15:44, pages 50612-50625.
Crossref
Crossref
Adewale Oluwaseun Fadaka, Taiwo Akinsoji, Ashwil Klein, Abram Madimabe Madiehe, Mervin Meyer, Marshall Keyster, Lucky Mashudu Sikhwivhilu & Nicole Remaliah Samantha Sibuyi. (2023) Stage-specific treatment of colorectal cancer: A microRNA-nanocomposite approach. Journal of Pharmaceutical Analysis 13:11, pages 1235-1251.
Crossref
Crossref
Jingcai Wang, Chunyan Guo, Lixin Yang, Peng Sun & Xiaoqing Jing. (2023) Peripheral blood microR-146a and microR-29c expression in children with Mycoplasma pneumoniae pneumonia and its clinical value. Italian Journal of Pediatrics 49:1.
Crossref
Crossref
Man Wang, Fei Yu & Peifeng Li. (2023) Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications. Frontiers in Immunology 14.
Crossref
Crossref
Elmira Roshani Asl, Sajed Sarabandi, Behrouz Shademan, Kourosh Dalvandi, Golshan sheikhansari & Alireza Nourazarian. (2023) MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. Biochemistry and Biophysics Reports 35, pages 101519.
Crossref
Crossref
Neha Datta, Charlotte Johnson, Dina Kao, Pratik Gurnani, Cameron Alexander, Christos Polytarchou & Tanya M. Monaghan. (2023) MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis. Pharmacological Research 194, pages 106870.
Crossref
Crossref
Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, Padmavati Sahare, Surajit Pathak, Antara Banerjee, Asim K. Duttaroy & Sujay Paul. (2023) Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Qi Zhang, Jing Pan, Donghai Xiong, Junjun Zheng, Kristi N. McPherson, Sangbeom Lee, Mofei Huang, Yitian Xu, Shu-hsia Chen, Yian Wang, Lea Hildebrandt Ruiz & Ming You. (2023) Aerosolized miR-138-5p and miR-200c targets PD-L1 for lung cancer prevention. Frontiers in Immunology 14.
Crossref
Crossref
Saeid Hatam. (2023) MicroRNAs Improve Cancer Treatment Outcomes Through Personalized Medicine. MicroRNA 12:2, pages 92-98.
Crossref
Crossref
Faezeh Tolue Ghasaban, Iman Akhlaghipour, Negin Taghehchian, Amirhosein Maharati, Bahram Memar & Meysam Moghbeli. (2023) MicroRNA-185: A non-invasive diagnostic and prognostic tumor marker. Process Biochemistry 130, pages 645-658.
Crossref
Crossref
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, Muhanad A. Abdulsamad, Abdulmutalib A. Allaq, Adrianna Gielecińska & Renata Kontek. (2023) Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets. Cancers 15:13, pages 3298.
Crossref
Crossref
Timothy Borjas, Asha Jacob, Molly Kobritz, Vihas Patel, Gene F. Coppa, Monowar Aziz & Ping Wang. (2023) A novel miRNA mimic attenuates organ injury after hepatic ischemia/reperfusion. Journal of Trauma and Acute Care Surgery 94:5, pages 702-709.
Crossref
Crossref
Marc Thibonnier & Sujoy Ghosh. (2023) Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs. International Journal of Molecular Sciences 24:8, pages 7126.
Crossref
Crossref
Yazmin Brown, Susan Hua & Pradeep S. Tanwar. (2023) Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology. Matrix Biology 118, pages 16-46.
Crossref
Crossref
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, Paras Famta, Saurabh Srivastava, Shashi Bala Singh & Dharmendra Kumar Khatri. (2023) Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics. Mechanisms of Ageing and Development 211, pages 111800.
Crossref
Crossref
Agata Poniewierska-Baran, Łukasz Zadroga, Edo Danilyan, Paulina Małkowska, Paulina Niedźwiedzka-Rystwej & Andrzej Pawlik. (2023) MicroRNA as a Diagnostic Tool, Therapeutic Target and Potential Biomarker in Cutaneous Malignant Melanoma Detection—Narrative Review. International Journal of Molecular Sciences 24:6, pages 5386.
Crossref
Crossref
Bhaskar Roy & Yogesh Dwivedi. (2023) An insight into the sprawling microverse of microRNAs in depression pathophysiology and treatment response. Neuroscience & Biobehavioral Reviews 146, pages 105040.
Crossref
Crossref
Dhanashree Murugan & Loganathan Rangasamy. (2023) A perspective to weaponize microRNAs against lung cancer. Non-coding RNA Research 8:1, pages 18-32.
Crossref
Crossref
Ali Shayeghpour, Mohammad-Moien Forghani-Ramandi, Setayesh Solouki, Amin Hosseini, Parastoo Hosseini, Sara Khodayar, Mahsa Hasani, Sepehr Aghajanian, Zeinab Siami, Mohadeseh Zarei Ghobadi & Sayed-Hamidreza Mozhgani. (2023) Identification of novel miRNAs potentially involved in the pathogenesis of adult T-cell leukemia/lymphoma using WGCNA followed by RT-qPCR test of hub genes. Infectious Agents and Cancer 18:1.
Crossref
Crossref
Timothy Borjas, Asha Jacob, Molly Kobritz, Gaifeng Ma, Chuyi Tan, Vihas Patel, Gene F. Coppa, Monowar Aziz & Ping Wang. (2023) An engineered miRNA PS-OMe miR130 inhibits acute lung injury by targeting eCIRP in sepsis. Molecular Medicine 29:1.
Crossref
Crossref
Samantha Hayward, Kevon Parmesar, Gavin I. Welsh, Matthew Suderman & Moin A. Saleem. (2023) Epigenetic Mechanisms and Nephrotic Syndrome: A Systematic Review. Biomedicines 11:2, pages 514.
Crossref
Crossref
Min Yang, Ying Zhang, Min Li, Xinglong Liu & Mohammad Darvishi. (2023) The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell International 23:1.
Crossref
Crossref
Mohammad H. Ghazimoradi, Naeim Karimpour-Fard & Sadegh Babashah. (2023) The Promising Role of Non-Coding RNAs as Biomarkers and Therapeutic Targets for Leukemia. Genes 14:1, pages 131.
Crossref
Crossref
Gavin M. Traber & Ai-Ming Yu. (2023) RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies. Journal of Pharmacology and Experimental Therapeutics 384:1, pages 133-154.
Crossref
Crossref
Marie C. Sell, Charmaine A. Ramlogan-Steel, Jason C. Steel & Bijay P. Dhungel. (2023) MicroRNAs in cancer metastasis: biological and therapeutic implications. Expert Reviews in Molecular Medicine 25.
Crossref
Crossref
Riya Chaudhary, Aparna Meher, Pandikannan Krishnamoorthy & Himanshu Kumar. (2023) Interplay of host and viral factors in inflammatory pathway mediated cytokine storm during RNA virus infection. Current Research in Immunology 4, pages 100062.
Crossref
Crossref
Caroline Zhang & Biliang Zhang. (2022) RNA therapeutics: updates and future potential. Science China Life Sciences 66:1, pages 12-30.
Crossref
Crossref
Pallabi Sengupta, Nilanjan Banerjee, Anindya Dutta, Madhurima Chaudhuri & Subhrangsu Chatterjee. 2023. Nucleic Acid Biology and its Application in Human Diseases. Nucleic Acid Biology and its Application in Human Diseases
321
348
.
Abdul Fatah A. Samad & Mohd Farizal Kamaroddin. (2022)
Innovative approaches in transforming
microRNAs
into therapeutic tools
. WIREs RNA 14:1.
Crossref
Crossref
Asmita Deka Dey, Satar Yousefiasl, Arun Kumar, Farnaz Dabbagh Moghaddam, Ilnaz Rahimmanesh, Mohamadmahdi Samandari, Sumit Jamwal, Aziz Maleki, Abbas Mohammadi, Navid Rabiee, Ana Cláudia Paiva‐Santos, Ali Tamayol, Esmaeel Sharifi & Pooyan Makvandi. (2022)
miRNA
‐encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: Biogenesis, mechanisms, and delivery nanocarriers
. Bioengineering & Translational Medicine 8:1.
Crossref
Crossref
Hussein Riyadh Abdul Kareem Al-Hetty, Sada Jasim Abdulameer, Maha Waleed Alghazali, Mustafa Aljaberi, Marwan Mahmood Saleh, Ahmed AbdulJabbar Suleiman & Abduladheem Turki Jalil. (2022) Contributions and therapeutic potential of tumor-derived microRNAs containing exosomes to cancer progression. Gene Reports 29, pages 101672.
Crossref
Crossref
Maryam Mahjoubin-Tehran, Seyed Hamid Aghaee-Bakhtiari, Amirhossein Sahebkar, Alexandra E. Butler, Reza Kazemi Oskuee & Amin Jalili. (2022) In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis. Scientific Reports 12:1.
Crossref
Crossref
Kathy Yuen Yee Chan, Po Yee Chung, Chi Zhang, Ellen Ngar Yun Poon, Alex Wing Kwan Leung & Kam Tong Leung. (2022) R4 RGS proteins as fine tuners of immature and mature hematopoietic cell trafficking. Journal of Leukocyte Biology 112:4, pages 785-797.
Crossref
Crossref
Maria J. Donde, Adam M. Rochussen, Saksham Kapoor & Alexander I. Taylor. (2022) Targeting non-coding RNA family members with artificial endonuclease XNAzymes. Communications Biology 5:1.
Crossref
Crossref
Mamta Panda, Elora Kalita, Satyendra Singh, Ketan Kumar, Abhishek Rao & Vijay Kumar Prajapati. (2022) MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies. Life Sciences 305, pages 120761.
Crossref
Crossref
Chakresh Kumar Jain, Poornima Srivastava, Amit Kumar Pandey, Nisha Singh & R Suresh Kumar. (2022) miRNA therapeutics in precision oncology: a natural premium to nurture. Exploration of Targeted Anti-tumor Therapy, pages 511-532.
Crossref
Crossref
Nuria Lafuente-Gómez, Shiqi Wang, Flavia Fontana, Mónica Dhanjani, David García-Soriano, Alexandra Correia, Milagros Castellanos, Ciro Rodriguez Diaz, Gorka Salas, Hélder A. Santos & Álvaro Somoza. (2022) Synergistic immunomodulatory effect in macrophages mediated by magnetic nanoparticles modified with miRNAs. Nanoscale 14:31, pages 11129-11138.
Crossref
Crossref
Goknur Kara, Banu Arun, George A. Calin & Bulent Ozpolat. (2022) miRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers 14:15, pages 3818.
Crossref
Crossref
Mina Zare, Rakesh Pemmada, Maya Madhavan, Aswathy Shailaja, Seeram Ramakrishna, Sumodan Padikkala Kandiyil, James M. Donahue & Vinoy Thomas. (2022) Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics. Pharmaceutics 14:8, pages 1620.
Crossref
Crossref
Behnoush Sohrabi, Behnaz Dayeri, Elahe Zahedi, Shahrouz Khoshbakht, Najme Nezamabadi Pour, Hamta Ranjbar, Abolfazl Davari Nejad, Mahdi Noureddini & Behrang Alani. (2022) Mesenchymal stem cell (MSC)-derived exosomes as novel vehicles for delivery of miRNAs in cancer therapy. Cancer Gene Therapy 29:8-9, pages 1105-1116.
Crossref
Crossref
Tanwi Vartak, Soundharya Kumaresan & Eoin Brennan. (2022) Decoding microRNA drivers in atherosclerosis. Bioscience Reports 42:7.
Crossref
Crossref
Yuzhuo Sun, Fei Xiong, Yongke Sun, Youjie Zhao & Yong Cao. (2022) A miRNA Target Prediction Model Based on Distributed Representation Learning and Deep Learning. Computational and Mathematical Methods in Medicine 2022, pages 1-12.
Crossref
Crossref
Ying Zhang, Xiao‐Xu Han, Xiao‐Meng Lin, Zhong Li & Jun‐Hua Zhang. (2022)
miR
‐450a exerts oncosuppressive effects in breast carcinoma by targeting
CREB1
. The Kaohsiung Journal of Medical Sciences 38:7, pages 643-652.
Crossref
Crossref
Colleen Yi & Ai-Ming Yu. (2022) MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Piyush Gondaliya, Adil Ali Sayyed, Palak Bhat, Mukund Mali, Neha Arya, Amit Khairnar & Kiran Kalia. (2022) Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-155 Inhibitor Ameliorate Diabetic Wound Healing. Molecular Pharmaceutics 19:5, pages 1294-1308.
Crossref
Crossref
Priya Mondal, Bhavjot Kaur, Jagadish Natesh & Syed Musthapa Meeran. (2022) The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications. Seminars in Cell & Developmental Biology 124, pages 99-113.
Crossref
Crossref
Jyothsna Manikkath, Padacherri Vethil Jishnu, Peter R Wich, Aparna Manikkath & Raghu Radhakrishnan. (2022) Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine 17:3, pages 181-195.
Crossref
Crossref
Mark S. Gibson, Cláudia Noronha-Estima & Margarida Gama-Carvalho. (2022) Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection. Genes 13:2, pages 273.
Crossref
Crossref
Martina Del Gaizo, Ilaria Sergio, Sara Lazzari, Samantha Cialfi, Maria Pelullo, Isabella Screpanti & Maria Pia Felli. (2022) MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences 23:2, pages 829.
Crossref
Crossref
Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Suvrendu Sankar Kar & Sandeep Kumar Dash. (2022) Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation. Current Research in Pharmacology and Drug Discovery 3, pages 100131.
Crossref
Crossref
Giulia Cosentino, Ilaria Plantamura & Marilena V. Iorio. 2022. MicroRNA in Human Malignancies. MicroRNA in Human Malignancies
195
201
.
Alberto M. Arenas, Alvaro Andrades, Juan Rodrigo Patiño-Mercau, Juan Sanjuan-Hidalgo, Marta Cuadros, Daniel J. García, Paola Peinado, Maria Isabel Rodriguez, Carlos Baliñas-Gavira, Juan Carlos Álvarez-Perez & Pedro P. Medina. 2022. MicroRNA in Human Malignancies. MicroRNA in Human Malignancies
153
164
.
Adriane F. Evangelista, Ana Julia A. de Freitas, Muriele B. Varuzza, Rhafaela L. Causin, Tatiana T. Komoto & Marcia M. C. Marques. 2022. Transcriptomics in Health and Disease. Transcriptomics in Health and Disease
317
340
.
Evelyn Gabriela Bañuelos-Villegas, María Fernanda Pérez-yPérez & Luis Marat Alvarez-Salas. (2021) Cervical Cancer, Papillomavirus, and miRNA Dysfunction. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Yuan Gu, Gianni Pais, Vivien Becker, Christina Körbel, Emmanuel Ampofo, Elke Ebert, Johannes Hohneck, Nicole Ludwig, Eckart Meese, Rainer M. Bohle, Yingjun Zhao, Michael D. Menger & Matthias W. Laschke. (2021) Suppression of endothelial miR-22 mediates non-small cell lung cancer cell-induced angiogenesis. Molecular Therapy - Nucleic Acids 26, pages 849-864.
Crossref
Crossref
Gurjit Singh & Kenneth B. Storey. (2021) MicroRNA Cues from Nature: A Roadmap to Decipher and Combat Challenges in Human Health and Disease?. Cells 10:12, pages 3374.
Crossref
Crossref
Amro M. Soliman, Mohamed Soliman, Srijit Das & Seong Lin Teoh. (2021) MicroRNA as a Biomarker for Diagnostic, Prognostic, and Therapeutic Purpose in Urinary Tract Cancer. Processes 9:12, pages 2136.
Crossref
Crossref
Rald V. M. Groven, Johan van Koll, Martijn Poeze, Taco J. Blokhuis & Martijn van Griensven. (2021) miRNAs Related to Different Processes of Fracture Healing: An Integrative Overview. Frontiers in Surgery 8.
Crossref
Crossref
Mohammad Yahya Momin, Ravinder Reddy Gaddam, Madeline Kravitz, Anisha Gupta & Ajit Vikram. (2021) The Challenges and Opportunities in the Development of MicroRNA Therapeutics: A Multidisciplinary Viewpoint. Cells 10:11, pages 3097.
Crossref
Crossref
Po-Shuan Huang, Chia-Jung Liao, Ya-Hui Huang, Chau-Ting Yeh, Cheng-Yi Chen, Hui-Chi Tang, Cheng-Chih Chang & Kwang-Huei Lin. (2021) Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. Cancers 13:21, pages 5361.
Crossref
Crossref
Khairunnisa’ Md Yusof, Kira Groen, Rozita Rosli & Kelly A. Avery-Kiejda. (2021) Crosstalk Between microRNAs and the Pathological Features of Secondary Lymphedema. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Zhi Xiong Chong, Swee Keong Yeap & Wan Yong Ho. (2021) Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma. Pharmacological Research 172, pages 105818.
Crossref
Crossref
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Vinay Patel, Ola A Al-Ewaidat, Fahriba Tasnim, Sandeep Padda, Ayden Charlene Cooper & Gutteridge Jean-Charles. (2021) Exosome-Derived microRNA: Efficacy in Cancer. Cureus.
Crossref
Crossref
Matthew G. Davey, Molly Davies, Aoife J. Lowery, Nicola Miller & Michael J. Kerin. (2021) The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment. International Journal of Molecular Sciences 22:15, pages 8290.
Crossref
Crossref
Fatemeh Radmanesh, Hamid Sadeghi Abandansari, Mohammad Hossein Ghanian, Sara Pahlavan, Fahimeh Varzideh, Saeed Yakhkeshi, Mehdi Alikhani, Sharif Moradi, Thomas Braun & Hossein Baharvand. (2021) Hydrogel-mediated delivery of microRNA-92a inhibitor polyplex nanoparticles induces localized angiogenesis. Angiogenesis 24:3, pages 657-676.
Crossref
Crossref
Gijung Kwak, Hyosuk Kim, Jooho Park, Eun Hye Kim, Hochung Jang, Geonhee Han, Sun Young Wang, Yoosoo Yang, Ick Chan Kwon & Sun Hwa Kim. (2021)
A Trojan-Horse Strategy by
In Situ
Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA
. ACS Nano 15:7, pages 11369-11384.
Crossref
Crossref
Zahra Sadat Razavi, Kasra Asgarpour, Maryam Mahjoubin-Tehran, Susan Rasouli, Haroon Khan, Mohammad Karim Shahrzad, Michael R. Hamblin & Hamed Mirzaei. (2021) Angiogenesis-related non-coding RNAs and gastrointestinal cancer. Molecular Therapy - Oncolytics 21, pages 220-241.
Crossref
Crossref
Javid Sadri Nahand, Layla Shojaie, Seyed Amirreza Akhlagh, Mohammad Saeid Ebrahimi, Hamid Reza Mirzaei, Hossein Bannazadeh Baghi, Maryam Mahjoubin-Tehran, Nima Rezaei, Michael R. Hamblin, Vida Tajiknia, Neda Rahimian & Hamed Mirzaei. (2021) Cell death pathways and viruses: Role of microRNAs. Molecular Therapy - Nucleic Acids 24, pages 487-511.
Crossref
Crossref
Riccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, Sharon A. O’Toole, John J. O’Leary, Mark P. Ward, Neil T. Conlon, Maja Sabol, Petar Ozretić, Ayse Elif Erson-Bensan, Nicholas Reed, Antonio Giordano, C. Simon Herrington & Jean Calleja-Agius. (2021) Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview. International Journal of Molecular Sciences 22:8, pages 3822.
Crossref
Crossref
Giulia Romano, Mario Acunzo & Patrick Nana-Sinkam. (2021) microRNAs as Novel Therapeutics in Cancer. Cancers 13:7, pages 1526.
Crossref
Crossref
Zhi Xiong Chong, Swee Keong Yeap & Wan Yong Ho. (2021) Regulation of autophagy by microRNAs in human breast cancer. Journal of Biomedical Science 28:1.
Crossref
Crossref
Ewa Gajda, Małgorzata Grzanka, Marlena Godlewska & Damian Gawel. (2021) The Role of miRNA-7 in the Biology of Cancer and Modulation of Drug Resistance. Pharmaceuticals 14:2, pages 149.
Crossref
Crossref
Christos I. Papagiannopoulos, Nikoleta F. Theodoroula & Ioannis S. Vizirianakis. (2021) miR-16-5p Promotes Erythroid Maturation of Erythroleukemia Cells by Regulating Ribosome Biogenesis. Pharmaceuticals 14:2, pages 137.
Crossref
Crossref
Tomasz M. Grzywa, Klaudia Klicka & Paweł K. Włodarski. (2020) Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis. Cancers 12:12, pages 3709.
Crossref
Crossref
Amro M. Soliman, Teoh Seong Lin, Pasuk Mahakkanukrauh & Srijit Das. (2020) Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma. International Journal of Molecular Sciences 21:20, pages 7539.
Crossref
Crossref